DENTSPLY SIRONA Inc
NASDAQ:XRAY

Watchlist Manager
DENTSPLY SIRONA Inc Logo
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Watchlist
Price: 15.47 USD -2.4% Market Closed
Market Cap: 3.1B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one XRAY stock under the Base Case scenario is 44.42 USD. Compared to the current market price of 15.47 USD, DENTSPLY SIRONA Inc is Undervalued by 65%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XRAY Relative Value
Base Case
44.42 USD
Undervaluation 65%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
95
vs Industry
69
Median 3Y
1.7
Median 5Y
2
Industry
2.2
Forward
0.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-8
Median 5Y
-7.6
Industry
21.5
Forward
8.2
More Details
7
P/OCF
P/OCF
Price to OCF
7
vs History
95
vs Industry
44
Median 3Y
11.7
Median 5Y
14.6
Industry
13.7
More Details
6.2
P/FCFE
P/FCFE
Price to FCFE
6.2
vs History
95
vs Industry
32
Median 3Y
17.6
Median 5Y
17.6
Industry
20.1
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
88
vs Industry
49
Median 3Y
1.9
Median 5Y
2
Industry
2.1
More Details
1.2
EV/S
EV/S
Enterprise Value to Sales
1.2
vs History
95
vs Industry
62
Median 3Y
2
Median 5Y
2.3
Industry
2.3
Forward
1.2
More Details
2.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.2
vs History
95
vs Industry
66
Median 3Y
3.8
Median 5Y
4.3
Industry
4.8
More Details
7.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.2
vs History
95
vs Industry
39
Median 3Y
11
Median 5Y
13.1
Industry
11.5
Forward
6
More Details
17
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17
vs History
90
vs Industry
23
Median 3Y
23.8
Median 5Y
25.1
Industry
15.7
Forward
8
More Details
9.7
EV/OCF
EV/OCF
Enterprise Value to OCF
9.7
vs History
95
vs Industry
37
Median 3Y
13.8
Median 5Y
16.9
Industry
13.6
More Details
15.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.4
vs History
93
vs Industry
27
Median 3Y
18.7
Median 5Y
21.9
Industry
17.3
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
95
vs Industry
63
Median 3Y
1.1
Median 5Y
1.3
Industry
1.8
More Details

Multiples Across Competitors

XRAY Competitors Multiples
DENTSPLY SIRONA Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
3.1B USD 0.8 -3.4 7.2 17
JP
Hoya Corp
TSE:7741
6.2T JPY 7.1 30.5 18.9 22.6
CH
Alcon AG
SIX:ALC
35.1B CHF 4.3 37.8 17.4 32.9
DK
Coloplast A/S
CSE:COLO B
141.9B DKK 5.1 31.2 18 21.2
US
Align Technology Inc
NASDAQ:ALGN
12.6B USD 3.2 29.9 14.2 17.2
UK
ConvaTec Group PLC
LSE:CTEC
5.9B GBP 3.5 41.6 210.2 343.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.5B CNY 12.9 32.6 28.2 28.2
CH
Ypsomed Holding AG
SIX:YPSN
5.2B CHF 8.4 69.7 33.5 62.9
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.1 46.1 21.2 37.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.1B USD 3.3 20.1 9.2 10.5
KR
HLB Inc
KOSDAQ:028300
7T KRW 93.7 -37.1 -65.9 -62.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Average EV/EBITDA: 37.8
7.2
12%
0.6
JP
Hoya Corp
TSE:7741
18.9
9%
2.1
CH
Alcon AG
SIX:ALC
17.4
10%
1.7
DK
Coloplast A/S
CSE:COLO B
18
9%
2
US
Align Technology Inc
NASDAQ:ALGN
14.2
15%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
210.2
11%
19.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.2
18%
1.6
CH
Ypsomed Holding AG
SIX:YPSN
33.5
31%
1.1
US
Merit Medical Systems Inc
NASDAQ:MMSI
21.2
12%
1.8
US
Lantheus Holdings Inc
NASDAQ:LNTH
9.2
21%
0.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -65.9 N/A N/A

See Also

Summary
XRAY intrinsic value, competitors valuation, and company profile.
DCF Valuation
XRAY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XRAY stock valuation using valuation multiples.
Wall Street Estimates
XRAY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XRAY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 256,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.